title: Visual evoked potentials and serum magnesium levels in juvenile migraine patients.
abstract: Changes in visual evoked potentials and decreased intracellular magnesium levels have been separately described in patients affected by migraine both during the attacks and in the interictal periods. An inverse correlation between increased P100 amplitude and lowered serum magnesium levels was found in children suffering from migraine with and without aura in a headache-free period. A 20-day treatment with oral magnesium pidolate seemed to normalize the magnesium balance in 90% of patients. After treatment, the reduced P100 amplitude confirmed the inverse correlation with the serum magnesium level. These data seem to suggest the hypothesis that higher visual evoked potential amplitude and low brain magnesium level can both be an expression of neuronal hyperexcitability of the visual pathways related to a lowered threshold for migraine attacks.
authors.affiliation: Servizio di Neurofisiopatologia, University of L'Aquila, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Aloisi
authors.forename: A
authors.initials: A
authors.lastname: Marrelli
authors.forename: C
authors.initials: C
authors.lastname: Porto
authors.forename: E
authors.initials: E
authors.lastname: Tozzi
authors.forename: G
authors.initials: G
authors.lastname: Cerone
mesh_terms: D000293:Adolescent; D002648:Child; D005074:Evoked Potentials, Visual; D005260:Female; D006801:Humans; D008274:Magnesium / Q000097:blood*; D008297:Male; D008881:Migraine Disorders / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology*; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D018781:Tension-Type Headache / Q000097:blood / Q000503:physiopathology
chemical_list: D008274:Magnesium; D011761:Pyrrolidonecarboxylic Acid